骨髓间充质干细胞在骨科疾病中的临床应用与研究进展
Clinical Applications and Research Progress of Bone Marrow Mesenchymal Stem Cells (BMSCs) in Orthopedic Diseases
摘要: 骨髓间充质干细胞(BMSCs)因其多向分化潜能、自我更新能力及旁分泌特性，已成为骨科疾病再生治疗的研究热点。近年研究聚焦于BMSCs在骨缺损、股骨头坏死、骨关节炎、脊髓损伤等难治性疾病中的应用机制与临床转化。BMSCs可通过分化为成骨细胞、软骨细胞及神经细胞，结合生物支架材料、基因修饰或药物干预，促进组织再生与功能恢复。本文系统综述了BMSC在骨折与骨缺损修复、股骨头坏死、骨关节炎、脊髓损伤等骨科难治性疾病中的研究进展，总结BMSCs在骨科疾病治疗中的应用现状，分析现存挑战，并展望其未来发展方向，以期为临床转化提供理论依据。
Abstract: Bone marrow mesenchymal stem cells (BMSCs) have emerged as a pivotal research focus in regenera-tive therapy for orthopedic diseases due to their multipotent differentiation capacity, self-renewal ability, and paracrine properties. Recent studies have concentrated on elucidating the mechanistic roles and clinical translation of BMSCs in refractory conditions such as bone defects, osteonecrosis of the femoral head (ONFH), osteoarthritis (OA), and spinal cord injury (SCI). BMSCs facilitate tissue regeneration and functional recovery through differentiation into osteoblasts, chondrocytes, and neural cells, combined with biomaterial scaffolds, genetic modification, or pharmacological interventions. This article systematically reviews advances in BMSC-based strategies for treating orthopedic refractory diseases, including fracture and bone defect repair, ONFH, OA, and SCI. It summarizes the current applications of BMSCs in orthopedic therapeutics, analyzes existing challenges, and proposes future directions to inform clinical translation with robust theoretical foundations.
文章引用：沈昌辉, 于智斌, 张俊. 骨髓间充质干细胞在骨科疾病中的临床应用与研究进展[J]. 临床医学进展, 2025, 15(6): 1498-1505. https://doi.org/10.12677/acm.2025.1561878

参考文献

[1] Koyuncu Irmak, D. and Karaoz, E. (2021) Generation of Induced Pluripotent Stem Cells from Human Bone Marrow-Derived Mesenchymal Stem Cells. In: Nagy, A. and Turksen, K., Eds., Methods in Molecular Biology, Springer, 17-29. [Google Scholar] [CrossRef] [PubMed]
[2] Zhou, C.C., Wu, Z.P. and Zou, S.J. (2020) The Study of Signal Pathway Regulating the Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells. Journal of Sichuan University. Medical Science Edition, 51, 777-782.
[3] Roddy, E., DeBaun, M.R., Daoud-Gray, A., Yang, Y.P. and Gardner, M.J. (2017) Treatment of Critical-Sized Bone Defects: Clinical and Tissue Engineering Perspectives. European Journal of Orthopaedic Surgery & Traumatology, 28, 351-362. [Google Scholar] [CrossRef] [PubMed]
[4] Lingayat, M.B., Baria, K., Muslim, S.M., Chavan, S.B. and Shaikh, S. (2023) Evaluation of Clinical and Functional Outcome of Total Hip Arthroplasty in Avascular Necrosis of Head of Femur in Adults. International Journal of Research in Orthopaedics, 9, 1236-1240. [Google Scholar] [CrossRef] 
[5] Ong, B., Wilson, J.R. and Henzel, M.K. (2020) Management of the Patient with Chronic Spinal Cord Injury. Medical Clinics of North America, 104, 263-278. [Google Scholar] [CrossRef] [PubMed]
[6] Drela, K., Stanaszek, L., Snioch, K., Kuczynska, Z., Wrobel, M., Sarzynska, S., et al. (2020) Bone Marrow-Derived from the Human Femoral Shaft as a New Source of Mesenchymal Stem/Stromal Cells: An Alternative Cell Material for Banking and Clinical Transplantation. Stem Cell Research & Therapy, 11, Article No. 262. [Google Scholar] [CrossRef] [PubMed]
[7] García-Muñoz, E. and Vives, J. (2021) Towards the Standardization of Methods of Tissue Processing for the Isolation of Mesenchymal Stromal Cells for Clinical Use. Cytotechnology, 73, 513-522. [Google Scholar] [CrossRef] [PubMed]
[8] Gao, Q., Wang, L., Wang, S., Huang, B., Jing, Y. and Su, J. (2022) Bone Marrow Mesenchymal Stromal Cells: Identification, Classification, and Differentiation. Frontiers in Cell and Developmental Biology, 9, Article ID: 787118. [Google Scholar] [CrossRef] [PubMed]
[9] Xu, H., Wang, C., Liu, C., Li, J., Peng, Z., Guo, J., et al. (2022) Stem Cell-Seeded 3D-Printed Scaffolds Combined with Self-Assembling Peptides for Bone Defect Repair. Tissue Engineering Part A, 28, 111-124. [Google Scholar] [CrossRef] [PubMed]
[10] Tan, Y., Ju, S., Wang, Q., Zhong, R., Gao, J., Wang, M., et al. (2024) Shuanglongjiegu Pill Promoted Bone Marrow Mesenchymal Stem Cell Osteogenic Differentiation by Regulating the miR-217/RUNX2 Axis to Activate Wnt/β-Catenin Pathway. Journal of Orthopaedic Surgery and Research, 19, Article No. 617. [Google Scholar] [CrossRef] [PubMed]
[11] Qin, S. and Liu, D. (2024) Long Non‐Coding RNA H19 Mediates Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells through the miR-29b-3p/DKK1 Axis. Journal of Cellular and Molecular Medicine, 28, e18287. [Google Scholar] [CrossRef] [PubMed]
[12] Chen, B., Chen, Q., Zhang, H., Zhang, D., Li, C., Ma, K., et al. (2024) 3D‐Printed Dual‐Bionic Scaffolds to Promote Osteoconductivity and Angiogenesis for Large Segment Bone Restoration. Advanced Functional Materials, 35, Article ID: 2422691. [Google Scholar] [CrossRef] 
[13] Zhou, L., Quan, R., Yang, J. and Xu, H. (2021) Healing of Bone Defects by Induced Pluripotent Stem Cell-Derived Bone Marrow Mesenchymal Stem Cells Seeded on Hydroxyapatite-Zirconia. Annals of Translational Medicine, 9, 1723-1723. [Google Scholar] [CrossRef] [PubMed]
[14] Lin, K., Xia, L., Li, H., Jiang, X., Pan, H., Xu, Y., et al. (2013) Enhanced Osteoporotic Bone Regeneration by Strontium-Substituted Calcium Silicate Bioactive Ceramics. Biomaterials, 34, 10028-10042. [Google Scholar] [CrossRef] [PubMed]
[15] Majeed, M.H. and Abd Alsaheb, N.K. (2022) Mechanical Property Evaluation of PLA/Soybean Oil Epoxidized Acrylate Three-Dimensional Scaffold in Bone Tissue Engineering. Key Engineering Materials, 911, 17-26. [Google Scholar] [CrossRef] 
[16] Maremanda, K.P., Sundar, I.K. and Rahman, I. (2019) Protective Role of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Cigarette Smoke-Induced Mitochondrial Dysfunction in Mice. Toxicology and Applied Pharmacology, 385, Article ID: 114788. [Google Scholar] [CrossRef] [PubMed]
[17] Deng, L., Yi, S., Yin, X., Li, Y. and Luan, Q. (2022) Downregulating mfn2 Promotes the Differentiation of Induced Pluripotent Stem Cells into Mesenchymal Stem Cells through the PI3K/Akt/GSK-3β/Wnt Signaling Pathway. Stem Cells and Development, 31, 181-194. [Google Scholar] [CrossRef] [PubMed]
[18] Wang, X., Gao, J., Wang, Y., Zhao, B., Zhang, Y., Han, F., et al. (2017) Curcumin Pretreatment Prevents Hydrogen Peroxide-Induced Oxidative Stress through Enhanced Mitochondrial Function and Deactivation of Akt/Erk Signaling Pathways in Rat Bone Marrow Mesenchymal Stem Cells. Molecular and Cellular Biochemistry, 443, 37-45. [Google Scholar] [CrossRef] [PubMed]
[19] Li, Q., Gao, Z., Chen, Y. and Guan, M. (2017) The Role of Mitochondria in Osteogenic, Adipogenic and Chondrogenic Differentiation of Mesenchymal Stem Cells. Protein & Cell, 8, 439-445. [Google Scholar] [CrossRef] [PubMed]
[20] Lim, W.B. and Al-Dadah, O. (2022) Conservative Treatment of Knee Osteoarthritis: A Review of the Literature. World Journal of Orthopedics, 13, 212-229. [Google Scholar] [CrossRef] [PubMed]
[21] Mariani, C., Meneghetti, E., Zambon, D., Elena, N., Agueci, A. and Melchior, C. (2023) Use of Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Osteoarthritis: A Retrospective Long-Term Follow-Up Study. Journal of Clinical Orthopaedics and Trauma, 36, Article ID: 102084. [Google Scholar] [CrossRef] [PubMed]
[22] Xu, L., Wu, Y., Xiong, Z., Zhou, Y., Ye, Z. and Tan, W. (2016) Mesenchymal Stem Cells Reshape and Provoke Proliferation of Articular Chondrocytes by Paracrine Secretion. Scientific Reports, 6, Article No. 32705. [Google Scholar] [CrossRef] [PubMed]
[23] Zhang, Q., Shen, Y., Zhao, S., Jiang, Y., Zhou, D. and Zhang, Y. (2021) Exosomes miR-15a Promotes Nucleus Pulposus-Mesenchymal Stem Cells Chondrogenic Differentiation by Targeting MMP-3. Cellular Signalling, 86, Article ID: 110083. [Google Scholar] [CrossRef] [PubMed]
[24] Kenyon, J.D., Sergeeva, O., Somoza, R.A., Li, M., Caplan, A.I., Khalil, A.M., et al. (2019) Analysis of-5p and-3p Strands of miR-145 and miR-140 during Mesenchymal Stem Cell Chondrogenic Differentiation. Tissue Engineering Part A, 25, 80-90. [Google Scholar] [CrossRef] [PubMed]
[25] Zou, X., Xu, H. and Qian, W. (2024) Macrophage Polarization in the Osteoarthritis Pathogenesis and Treatment. Orthopaedic Surgery, 17, 22-35. [Google Scholar] [CrossRef] [PubMed]
[26] Kehoe, O., Cartwright, A., Askari, A., El Haj, A.J. and Middleton, J. (2014) Intra-Articular Injection of Mesenchymal Stem Cells Leads to Reduced Inflammation and Cartilage Damage in Murine Antigen-Induced Arthritis. Journal of Translational Medicine, 12, Article No. 157. [Google Scholar] [CrossRef] [PubMed]
[27] Lee, B., Lee, J.J., Jung, J. and Ju, J.H. (2025) Intra-Articular Injection of Human Bone Marrow-Derived Mesenchymal Stem Cells in Knee Osteoarthritis: A Randomized, Double-Blind, Controlled Trial. Cell Transplantation, 34, 1-13. [Google Scholar] [CrossRef] [PubMed]
[28] Bastos, R., Mathias, M., Andrade, R., Bastos, R., Balduino, A., Schott, V., et al. (2018) Intra-Articular Injections of Expanded Mesenchymal Stem Cells with and without Addition of Platelet-Rich Plasma Are Safe and Effective for Knee Osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy, 26, 3342-3350. [Google Scholar] [CrossRef] [PubMed]
[29] Hernigou, P., Delambre, J., Quiennec, S. and Poignard, A. (2020) Human Bone Marrow Mesenchymal Stem Cell Injection in Subchondral Lesions of Knee Osteoarthritis: A Prospective Randomized Study versus Contralateral Arthroplasty at a Mean Fifteen Year Follow-Up. International Orthopaedics, 45, 365-373. [Google Scholar] [CrossRef] [PubMed]
[30] Mautner, K., Carr, D., Whitley, J. and Bowers, R. (2019) Allogeneic versus Autologous Injectable Mesenchymal Stem Cells for Knee Osteoarthritis: Review and Current Status. Techniques in Orthopaedics, 34, 244-256. [Google Scholar] [CrossRef] 
[31] He, L., He, T., Xing, J., Zhou, Q., Fan, L., Liu, C., et al. (2020) Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Protect Cartilage Damage and Relieve Knee Osteoarthritis Pain in a Rat Model of Osteoarthritis. Stem Cell Research & Therapy, 11, Article No. 276. [Google Scholar] [CrossRef] [PubMed]
[32] Zhang, J., Rong, Y., Luo, C. and Cui, W. (2020) Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Prevent Osteoarthritis by Regulating Synovial Macrophage Polarization. Aging, 12, 25138-25152. [Google Scholar] [CrossRef] [PubMed]
[33] Dasari, V.R. (2014) Mesenchymal Stem Cells in the Treatment of Spinal Cord Injuries: A Review. World Journal of Stem Cells, 6, 120-133. [Google Scholar] [CrossRef] [PubMed]
[34] Jeong, S.K., Choi, I. and Jeon, S.R. (2020) Current Status and Future Strategies to Treat Spinal Cord Injury with Adult Stem Cells. Journal of Korean Neurosurgical Society, 63, 153-162. [Google Scholar] [CrossRef] [PubMed]
[35] Wang, X., Ye, L., Zhang, K., Gao, L., Xiao, J. and Zhang, Y. (2020) Upregulation of MicroRNA‐200a in Bone Marrow Mesenchymal Stem Cells Enhances the Repair of Spinal Cord Injury in Rats by Reducing Oxidative Stress and Regulating Keap1/Nrf2 Pathway. Artificial Organs, 44, 744-752. [Google Scholar] [CrossRef] [PubMed]
[36] Jabermoradi, S., Paridari, P., Ramawad, H.A., et al. (2025) Stem Cell-Derived Exosomes as a Therapeutic Option for Spinal Cord Injuries: A Systematic Review and Meta-Analysis. Archives of Academic Emergency Medicine, 13, e2.
[37] Gou, Y., Liu, D., Liu, J. and Sun, H. (2018) Protective Effect of Transplantation of Bone Mesenchymal Stem Cells on Demyelination in Spinal Cord Injury. Chinese Journal of Biotechnology, 34, 761-776.
[38] Anna, Z., Katarzyna, J., Joanna, C., Barczewska, M., Joanna, W. and Wojciech, M. (2017) Therapeutic Potential of Olfactory Ensheathing Cells and Mesenchymal Stem Cells in Spinal Cord Injuries. Stem Cells International, 2017, Article ID: 3978595. [Google Scholar] [CrossRef] [PubMed]
[39] Bai, J., Liu, G., Gao, Y., Zhang, X., Niu, G. and Zhang, H. (2024) Co-Culturing Neural and Bone Mesenchymal Stem Cells in Photosensitive Hydrogel Enhances Spinal Cord Injury Repair. Frontiers in Bioengineering and Biotechnology, 12, Article ID: 1431420. [Google Scholar] [CrossRef] [PubMed]
[40] Yang, C., Wang, G., Ma, F., Yu, B., Chen, F., Yang, J., et al. (2018) Repeated Injections of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Significantly Promotes Functional Recovery in Rabbits with Spinal Cord Injury of Two Noncontinuous Segments. Stem Cell Research & Therapy, 9, Article No. 136. [Google Scholar] [CrossRef] [PubMed]
[41] Lim, J.S., Cui, X. and Konan, S. (2024) ThP2.17—Efficacy of Mesenchymal Stem Cells in the Treatment of Osteonecrosis of Femoral Head. British Journal of Surgery, 111, znae197.247. [Google Scholar] [CrossRef] 
[42] Li, X., Xu, X. and Wu, W. (2014) Comparison of Bone Marrow Mesenchymal Stem Cells and Core Decompression in Treatment of Osteonecrosis of the Femoral Head: A Meta-Analysis. International Journal of Clinical and Experimental Pathology, 7, 5024-5030.
[43] Wang, Z., Sun, Q., Zhang, F., Zhang, Q., Wang, L. and Wang, W. (2019) Core Decompression Combined with Autologous Bone Marrow Stem Cells versus Core Decompression Alone for Patients with Osteonecrosis of the Femoral Head: A Meta-Analysis. International Journal of Surgery, 69, 23-31. [Google Scholar] [CrossRef] [PubMed]
[44] Wu, Z.Y., Sun, Q., Liu, M., Grottkau, B.E., He, Z.X., Zou, Q., et al. (2020) Correlation between the Efficacy of Stem Cell Therapy for Osteonecrosis of the Femoral Head and Cell Viability. BMC Musculoskeletal Disorders, 21, Article No. 55. [Google Scholar] [CrossRef] [PubMed]
[45] Mao, Q., Jin, H., Liao, F., Xiao, L., Chen, D. and Tong, P. (2013) The Efficacy of Targeted Intraarterial Delivery of Concentrated Autologous Bone Marrow Containing Mononuclear Cells in the Treatment of Osteonecrosis of the Femoral Head: A Five Year Follow-Up Study. Bone, 57, 509-516. [Google Scholar] [CrossRef] [PubMed]
[46] Li, D., Xie, X., Yang, Z., Wang, C., Wei, Z. and Kang, P. (2023) Retraction: Enhanced Bone Defect Repairing Effects in Glucocorticoid-Induced Osteonecrosis of the Femoral Head Using a Porous Nano-Lithium-Hydroxyapatite/Gelatin Microsphere/Erythropoietin Composite Scaffold. Biomaterials Science, 11, 3365-3365. [Google Scholar] [CrossRef] [PubMed]

为你推荐